Do analysts rate PLYX or PYRGF?

Polaryx Therapeutics currently has a consensus target price of $7.67, suggesting a potential upside of 309.98%. Given Polaryx Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe Polaryx Therapeutics is more favorable than PyroGenesis Canada. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Polaryx Therapeutics 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.60 PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is PLYX or PYRGF more profitable?

Polaryx Therapeutics has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. Company Net Margins Return on Equity Return on Assets Polaryx Therapeutics N/A N/A N/A PyroGenesis Canada -115.14% N/A -60.81%

Does the media prefer PLYX or PYRGF?

In the previous week, PyroGenesis Canada had 2 more articles in the media than Polaryx Therapeutics. MarketBeat recorded 3 mentions for PyroGenesis Canada and 1 mentions for Polaryx Therapeutics. Polaryx Therapeutics' average media sentiment score of 0.00 equaled PyroGenesis Canada'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Polaryx Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PyroGenesis Canada 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate VTVT or PYRGF?

vTv Therapeutics currently has a consensus price target of $55.83, suggesting a potential upside of 64.75%. Given vTv Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe vTv Therapeutics is more favorable than PyroGenesis Canada. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score vTv Therapeutics 2 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50 PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Does the media prefer VTVT or PYRGF?

In the previous week, vTv Therapeutics and vTv Therapeutics both had 3 articles in the media. vTv Therapeutics' average media sentiment score of 0.34 beat PyroGenesis Canada's score of 0.00 indicating that vTv Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment vTv Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PyroGenesis Canada 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate NRXP or PYRGF?

NRx Pharmaceuticals presently has a consensus target price of $34.50, suggesting a potential upside of 900.00%. Given NRx Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts plainly believe NRx Pharmaceuticals is more favorable than PyroGenesis Canada. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NRx Pharmaceuticals 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is NRXP or PYRGF more profitable?

PyroGenesis Canada has a net margin of -115.14% compared to NRx Pharmaceuticals' net margin of -691.81%. Company Net Margins Return on Equity Return on Assets NRx Pharmaceuticals -691.81% N/A -63.92% PyroGenesis Canada -115.14% N/A -60.81%

Does the media prefer NRXP or PYRGF?

In the previous week, NRx Pharmaceuticals and NRx Pharmaceuticals both had 3 articles in the media. NRx Pharmaceuticals' average media sentiment score of 0.39 beat PyroGenesis Canada's score of 0.00 indicating that NRx Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NRx Pharmaceuticals 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PyroGenesis Canada 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer PYRGF or CPIX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Cumberland Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor PYRGF or CPIX?

In the previous week, PyroGenesis Canada had 1 more articles in the media than Cumberland Pharmaceuticals. MarketBeat recorded 3 mentions for PyroGenesis Canada and 2 mentions for Cumberland Pharmaceuticals. Cumberland Pharmaceuticals' average media sentiment score of 0.55 beat PyroGenesis Canada's score of 0.00 indicating that Cumberland Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PyroGenesis Canada 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cumberland Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer PYRGF or VANI?

Vivani Medical has a consensus target price of $3.75, indicating a potential upside of 171.74%. Given Vivani Medical's stronger consensus rating and higher probable upside, analysts plainly believe Vivani Medical is more favorable than PyroGenesis Canada. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Vivani Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Does the media favor PYRGF or VANI?

In the previous week, PyroGenesis Canada had 1 more articles in the media than Vivani Medical. MarketBeat recorded 3 mentions for PyroGenesis Canada and 2 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 0.25 beat PyroGenesis Canada's score of 0.00 indicating that Vivani Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PyroGenesis Canada 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Vivani Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

PyroGenesis Canada (PYRGF) Competitors

$0.14 +0.00 (+0.91%)

As of 03:55 PM Eastern

Compare

PYRGF vs. PLYX, VTVT, NRXP, CPIX, and VANI

Should you buy PyroGenesis Canada stock or one of its competitors? PyroGenesis Canada's main competitors and comparable companies include Polaryx Therapeutics (PLYX), vTv Therapeutics (VTVT), NRx Pharmaceuticals (NRXP), Cumberland Pharmaceuticals (CPIX), and Vivani Medical (VANI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does PyroGenesis Canada compare to Polaryx Therapeutics?

Polaryx Therapeutics (NASDAQ:PLYX) and PyroGenesis Canada (NASDAQ:PYRGF) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

In the previous week, PyroGenesis Canada had 2 more articles in the media than Polaryx Therapeutics. MarketBeat recorded 3 mentions for PyroGenesis Canada and 1 mentions for Polaryx Therapeutics. Polaryx Therapeutics' average media sentiment score of 0.00 equaled PyroGenesis Canada'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Polaryx Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PyroGenesis Canada	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Polaryx Therapeutics has higher earnings, but lower revenue than PyroGenesis Canada. Polaryx Therapeutics is trading at a lower price-to-earnings ratio than PyroGenesis Canada, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Polaryx Therapeutics	N/A	N/A	-$8.98M	-$0.08	N/A
PyroGenesis Canada	$9.14M	3.59	-$21.12M	-$0.04	N/A

0.0% of PyroGenesis Canada shares are owned by institutional investors. 45.8% of Polaryx Therapeutics shares are owned by insiders. Comparatively, 47.7% of PyroGenesis Canada shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Polaryx Therapeutics currently has a consensus target price of $7.67, suggesting a potential upside of 309.98%. Given Polaryx Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe Polaryx Therapeutics is more favorable than PyroGenesis Canada.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Polaryx Therapeutics	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
PyroGenesis Canada	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Polaryx Therapeutics has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%.

Company	Net Margins	Return on Equity	Return on Assets
Polaryx Therapeutics	N/A	N/A	N/A
PyroGenesis Canada	-115.14%	N/A	-60.81%

Summary

Polaryx Therapeutics beats PyroGenesis Canada on 7 of the 13 factors compared between the two stocks.

How does PyroGenesis Canada compare to vTv Therapeutics?

vTv Therapeutics (NASDAQ:VTVT) and PyroGenesis Canada (NASDAQ:PYRGF) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

vTv Therapeutics has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat vTv Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
vTv Therapeutics	N/A	-6.27%	-5.06%
PyroGenesis Canada	-115.14%	N/A	-60.81%

vTv Therapeutics currently has a consensus price target of $55.83, suggesting a potential upside of 64.75%. Given vTv Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe vTv Therapeutics is more favorable than PyroGenesis Canada.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
vTv Therapeutics	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
PyroGenesis Canada	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, vTv Therapeutics and vTv Therapeutics both had 3 articles in the media. vTv Therapeutics' average media sentiment score of 0.34 beat PyroGenesis Canada's score of 0.00 indicating that vTv Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
vTv Therapeutics	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PyroGenesis Canada	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PyroGenesis Canada has lower revenue, but higher earnings than vTv Therapeutics. vTv Therapeutics is trading at a lower price-to-earnings ratio than PyroGenesis Canada, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
vTv Therapeutics	$36.84M	3.62	-$26.97M	-$1.06	N/A
PyroGenesis Canada	$9.14M	3.59	-$21.12M	-$0.04	N/A

17.5% of vTv Therapeutics shares are held by institutional investors. Comparatively, 0.0% of PyroGenesis Canada shares are held by institutional investors. 6.0% of vTv Therapeutics shares are held by company insiders. Comparatively, 47.7% of PyroGenesis Canada shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

vTv Therapeutics has a beta of 0.28, meaning that its stock price is 72% less volatile than the broader market. Comparatively, PyroGenesis Canada has a beta of 0.27, meaning that its stock price is 73% less volatile than the broader market.

Summary

vTv Therapeutics beats PyroGenesis Canada on 10 of the 15 factors compared between the two stocks.

How does PyroGenesis Canada compare to NRx Pharmaceuticals?

NRx Pharmaceuticals (NASDAQ:NRXP) and PyroGenesis Canada (NASDAQ:PYRGF) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and risk.

PyroGenesis Canada has a net margin of -115.14% compared to NRx Pharmaceuticals' net margin of -691.81%.

Company	Net Margins	Return on Equity	Return on Assets
NRx Pharmaceuticals	-691.81%	N/A	-63.92%
PyroGenesis Canada	-115.14%	N/A	-60.81%

NRx Pharmaceuticals presently has a consensus target price of $34.50, suggesting a potential upside of 900.00%. Given NRx Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts plainly believe NRx Pharmaceuticals is more favorable than PyroGenesis Canada.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NRx Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
PyroGenesis Canada	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, NRx Pharmaceuticals and NRx Pharmaceuticals both had 3 articles in the media. NRx Pharmaceuticals' average media sentiment score of 0.39 beat PyroGenesis Canada's score of 0.00 indicating that NRx Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NRx Pharmaceuticals	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PyroGenesis Canada	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

4.3% of NRx Pharmaceuticals shares are held by institutional investors. Comparatively, 0.0% of PyroGenesis Canada shares are held by institutional investors. 6.4% of NRx Pharmaceuticals shares are held by company insiders. Comparatively, 47.7% of PyroGenesis Canada shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

NRx Pharmaceuticals has a beta of 2.18, meaning that its stock price is 118% more volatile than the broader market. Comparatively, PyroGenesis Canada has a beta of 0.27, meaning that its stock price is 73% less volatile than the broader market.

PyroGenesis Canada has higher revenue and earnings than NRx Pharmaceuticals. NRx Pharmaceuticals is trading at a lower price-to-earnings ratio than PyroGenesis Canada, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NRx Pharmaceuticals	$3.39M	44.01	-$28.62M	-$0.55	N/A
PyroGenesis Canada	$9.14M	3.59	-$21.12M	-$0.04	N/A

Summary

NRx Pharmaceuticals and PyroGenesis Canada tied by winning 7 of the 14 factors compared between the two stocks.

How does PyroGenesis Canada compare to Cumberland Pharmaceuticals?

PyroGenesis Canada (NASDAQ:PYRGF) and Cumberland Pharmaceuticals (NASDAQ:CPIX) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

0.0% of PyroGenesis Canada shares are held by institutional investors. Comparatively, 15.5% of Cumberland Pharmaceuticals shares are held by institutional investors. 47.7% of PyroGenesis Canada shares are held by insiders. Comparatively, 42.1% of Cumberland Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Cumberland Pharmaceuticals has a net margin of -34.40% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat Cumberland Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PyroGenesis Canada	-115.14%	N/A	-60.81%
Cumberland Pharmaceuticals	-34.40%	-28.81%	-9.25%

Cumberland Pharmaceuticals has higher revenue and earnings than PyroGenesis Canada. Cumberland Pharmaceuticals is trading at a lower price-to-earnings ratio than PyroGenesis Canada, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PyroGenesis Canada	$9.14M	3.59	-$21.12M	-$0.04	N/A
Cumberland Pharmaceuticals	$44.52M	2.64	-$2.84M	-$0.71	N/A

In the previous week, PyroGenesis Canada had 1 more articles in the media than Cumberland Pharmaceuticals. MarketBeat recorded 3 mentions for PyroGenesis Canada and 2 mentions for Cumberland Pharmaceuticals. Cumberland Pharmaceuticals' average media sentiment score of 0.55 beat PyroGenesis Canada's score of 0.00 indicating that Cumberland Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PyroGenesis Canada	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cumberland Pharmaceuticals	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PyroGenesis Canada	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cumberland Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

PyroGenesis Canada has a beta of 0.27, meaning that its stock price is 73% less volatile than the broader market. Comparatively, Cumberland Pharmaceuticals has a beta of 0.08, meaning that its stock price is 92% less volatile than the broader market.

Summary

PyroGenesis Canada and Cumberland Pharmaceuticals tied by winning 7 of the 14 factors compared between the two stocks.

How does PyroGenesis Canada compare to Vivani Medical?

PyroGenesis Canada (NASDAQ:PYRGF) and Vivani Medical (NASDAQ:VANI) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability, media sentiment and institutional ownership.

Vivani Medical has a consensus target price of $3.75, indicating a potential upside of 171.74%. Given Vivani Medical's stronger consensus rating and higher probable upside, analysts plainly believe Vivani Medical is more favorable than PyroGenesis Canada.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PyroGenesis Canada	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

PyroGenesis Canada has a beta of 0.27, meaning that its share price is 73% less volatile than the broader market. Comparatively, Vivani Medical has a beta of 2.35, meaning that its share price is 135% more volatile than the broader market.

Vivani Medical has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PyroGenesis Canada	-115.14%	N/A	-60.81%
Vivani Medical	N/A	-191.05%	-70.91%

PyroGenesis Canada has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than PyroGenesis Canada, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PyroGenesis Canada	$9.14M	3.59	-$21.12M	-$0.04	N/A
Vivani Medical	N/A	N/A	-$26.61M	-$0.35	N/A

0.0% of PyroGenesis Canada shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 47.7% of PyroGenesis Canada shares are owned by company insiders. Comparatively, 53.3% of Vivani Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, PyroGenesis Canada had 1 more articles in the media than Vivani Medical. MarketBeat recorded 3 mentions for PyroGenesis Canada and 2 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 0.25 beat PyroGenesis Canada's score of 0.00 indicating that Vivani Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PyroGenesis Canada	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Vivani Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Vivani Medical beats PyroGenesis Canada on 8 of the 15 factors compared between the two stocks.

Get PyroGenesis Canada News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PYRGF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PYRGF vs. The Competition

Export

Metric	PyroGenesis Canada	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$32.78M	$12.42B	$7.29B	$12.71B
Dividend Yield	N/A	2.62%	2.54%	10.79%
P/E Ratio	-2.41	780.42	271.39	24.10
Price / Sales	3.59	789.54	604.58	77.05
Price / Cash	N/A	15.47	29.03	36.90
Price / Book	-14.48	10.42	11.18	6.40
Net Income	-$21.12M	$2.79B	$3.46B	$348.28M
7 Day Performance	-6.58%	2.25%	1.98%	0.92%
1 Month Performance	8.79%	4.72%	7.32%	5.10%
1 Year Performance	-35.39%	7.07%	24.76%	16.16%

PyroGenesis Canada Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PYRGF PyroGenesis Canada	N/A	$0.14 +0.9%	N/A	-36.0%	$32.78M	$9.14M	N/A	90	News Coverage Gap Down
PLYX Polaryx Therapeutics	3.757 of 5 stars	$2.60 +4.0%	$7.67 +194.9%	N/A	$124.61M	N/A	N/A	11	Gap Up
VTVT vTv Therapeutics	3.1411 of 5 stars	$30.12 -2.4%	$55.83 +85.4%	+117.8%	$121.52M	$36.84M	N/A	9
NRXP NRx Pharmaceuticals	2.0571 of 5 stars	$3.27 -2.1%	$34.50 +955.0%	+34.8%	$121M	$1.23M	N/A	2	Earnings Report
CPIX Cumberland Pharmaceuticals	0.477 of 5 stars	$7.79 -1.4%	N/A	+132.5%	$118.37M	$44.52M	N/A	80

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PYRGF) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PyroGenesis Canada (PYRGF) Competitors

PYRGF vs. PLYX, VTVT, NRXP, CPIX, and VANI

How does PyroGenesis Canada compare to Polaryx Therapeutics?

Summary

How does PyroGenesis Canada compare to vTv Therapeutics?

Summary

How does PyroGenesis Canada compare to NRx Pharmaceuticals?

Summary

How does PyroGenesis Canada compare to Cumberland Pharmaceuticals?

Summary

How does PyroGenesis Canada compare to Vivani Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PYRGF vs. The Competition

PyroGenesis Canada Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PyroGenesis Canada (PYRGF) Competitors

PYRGF vs. PLYX, VTVT, NRXP, CPIX, and VANI

How does PyroGenesis Canada compare to Polaryx Therapeutics?

Does the media prefer PLYX or PYRGF?

Which has preferable earnings & valuation, PLYX or PYRGF?

Do insiders & institutionals hold more shares of PLYX or PYRGF?

Do analysts rate PLYX or PYRGF?

Is PLYX or PYRGF more profitable?

Summary

How does PyroGenesis Canada compare to vTv Therapeutics?

Is VTVT or PYRGF more profitable?

Do analysts rate VTVT or PYRGF?

Does the media prefer VTVT or PYRGF?

Which has stronger valuation & earnings, VTVT or PYRGF?

Do institutionals and insiders hold more shares of VTVT or PYRGF?

Which has more volatility and risk, VTVT or PYRGF?

Summary

How does PyroGenesis Canada compare to NRx Pharmaceuticals?

Is NRXP or PYRGF more profitable?

Do analysts rate NRXP or PYRGF?

Does the media prefer NRXP or PYRGF?

Do institutionals & insiders hold more shares of NRXP or PYRGF?

Which has more volatility & risk, NRXP or PYRGF?

Which has higher earnings and valuation, NRXP or PYRGF?

Summary

How does PyroGenesis Canada compare to Cumberland Pharmaceuticals?

Do insiders & institutionals hold more shares of PYRGF or CPIX?

Is PYRGF or CPIX more profitable?

Which has stronger earnings and valuation, PYRGF or CPIX?

Does the media favor PYRGF or CPIX?

Do analysts prefer PYRGF or CPIX?

Which has more risk & volatility, PYRGF or CPIX?

Summary

How does PyroGenesis Canada compare to Vivani Medical?

Do analysts prefer PYRGF or VANI?

Which has more volatility & risk, PYRGF or VANI?

Is PYRGF or VANI more profitable?

Which has better valuation and earnings, PYRGF or VANI?

Do insiders and institutionals hold more shares of PYRGF or VANI?

Does the media favor PYRGF or VANI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PYRGF vs. The Competition

PyroGenesis Canada Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools